485799-04-0 Usage
General Description
6-(Morpholin-4-yl)pyridine-3-boronic acid pinacol ester is a chemical compound commonly used in organic synthesis and medicinal chemistry. It is an important building block for the preparation of various pharmaceuticals and agrochemicals due to its boronic acid functionality, which allows for the formation of carbon-carbon bonds through Suzuki-Miyaura cross-coupling reactions. 6-(Morpholin-4-yl)pyridine-3-boronic acid pinacol ester is also known for its potential as a ligand in metal-catalyzed reactions and as a key intermediate in the synthesis of biologically active molecules. Its pinacol ester derivative provides stability and protection against potential side reactions, making it a valuable tool in the field of chemical synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 485799-04-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,5,7,9 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 485799-04:
(8*4)+(7*8)+(6*5)+(5*7)+(4*9)+(3*9)+(2*0)+(1*4)=220
220 % 10 = 0
So 485799-04-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H23BN2O3/c1-14(2)15(3,4)21-16(20-14)12-5-6-13(17-11-12)18-7-9-19-10-8-18/h5-6,11H,7-10H2,1-4H3
485799-04-0Relevant articles and documents
INDOLE AHR INHIBITORS AND USES THEREOF
-
, (2020/05/21)
The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS
-
Page/Page column 136, (2010/01/12)
Provided are compounds according to Formula (I), or stereoisomer, prodrug, polymorph, or pharmaceutically acceptable salt forms thereof, wherein X, Y, R1, R6 , R7, and R8 are as defined, which compounds are effective inhibitors of PI3-kinase and/or other medically and clinically relevant kinases. Also provided are pharmaceutical compositions and methods of using the compounds and compositions as PB -kinase and kinase inhibitors. More particularly, the compounds of the invention provide treatments and therapeutics for human diseases regulated by, or associated with, the activity of, PI3-kinases and/or protein kinases, or mutant or variant forms thereof.